Validation of a novel high-sensitivity cardiac troponin assay.

Back

ESC Professional Premium Access

Validation of a novel high-sensitivity cardiac troponin assay.

Session: Predicting risks

Topic: Biomarkers

Speaker: Doctor I. Restan (Stavanger, NO)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Ingar Ziad Restan

Stavanger University Hospital, Stavanger (Norway)

1 follower

7 more presentations in this session

Prevalence of reaching target low-density lipoprotein cholesterol (LDL-C) in very high-risk patients using high intensity lipid-modifying therapy.

Speaker: Mr A. Omar Khader (Rotterdam, NL)

Access

Abstract

Slides

Exploring adherence to an early rule-out pathway for myocardial infarction in the emergency department using mixed-methods

Speaker: Doctor A. Ferry (Edinburgh, GB)

Access

Abstract

Slides

Performance of high-sensitivity cardiac troponin T versus I for the early diagnosis of myocardial infarction

Speaker: Doctor L. Koechlin (Basel, CH)

Access

Abstract

Slides

An acoustic based risk score in addition to pre-test probability estimation for coronary artery disease improves risk classification in patients with suspected coronary artery disease

Speaker: Doctor L. Bjerking (Copenhagen, DK)

Access

Abstract

Slides

Impacts on the short-term outcome of patients with Tako-Tsubo syndrome

Speaker: Miss R. Mousavi (St Poelten, AT)

Access

Abstract

Slides

Access the full session

Predicting risks

Speakers: Doctor I. Restan, Mr A. Omar Khader, Doctor A. Ferry, Doctor L. Koechlin, Doctor L. Bjerking...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources